ArticleFrontiers in genetics2025
Geometry-enhanced graph neural networks accelerate circRNA therapeutic target discovery.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial: Advances in circRNA research: disease associations and diagnostic innovations.Frontiers in genetics · 2025Article
- Exploring the Clinical Transformation of circRNA as a Biomarker in Breast Cancer.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circular RNAs (circRNAs) play pivotal roles in various biological processes and disease progression, particularly in modulating drug responses and resistance mechanisms. Accurate prediction of circRNA-drug associations (CDAs) is essential for biomarker discovery and the advancement of therapeutic strategies. Although several computational approaches have been proposed for identifying novel circRNA therapeutic targets, their performance is often limited by inadequate modeling of higher-order geometric information within circRNA-drug interaction networks. To overcome these challenges, we propose G2CDA, a geometric graph representation learning framework specifically designed to enhance the identification of CDAs and facilitate therapeutic target discovery. G2CDA introduces torsion-based geometric encoding into the message propagation process of the circRNA-drug network. For each potential association, we construct local simplicial complexes, extract their geometric features, and integrate these features as adaptive weights during message propagation and aggregation. This design promotes a richer understanding of local topological structures, thereby improving the robustness and expressiveness of learned circRNA and drug representations. Extensive benchmark evaluations on public datasets demonstrate that G2CDA outperforms state-of-the-art CDA prediction models, particularly in identifying novel associations. Case studies further confirm its effectiveness by uncovering potential drug interactions with the ALDH3A2 and ANXA2 biomarkers. Collectively, G2CDA provides a robust and interpretable framework for accelerating circRNA-based therapeutic target discovery and streamlining drug development pipelines. Our code are archived in: https://github.com/lizhen5000/G2CDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.